Alcon Inc (ALC)

Dec 19, 2024

Alcon a top pick for 2025 at Needham on upcoming product launches - MSN

Dec 19, 2024

Dec 18, 2024

Alcon Top Pick for 2025 at Needham, added to Conviction List - MSN

Dec 18, 2024

Dec 17, 2024

Alcon stock named top pick for 2025 by Needham, positive on margin and earnings growth - Investing.com

Dec 17, 2024

Dec 16, 2024

Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030 - GlobeNewswire Inc.

Dec 16, 2024

Dec 13, 2024

RSI Alert: Alcon (ALC) Now Oversold - Nasdaq

Dec 13, 2024

Dec 13, 2024

Reasons to Retain Alcon Stock in Your Portfolio for Now - MSN

Dec 13, 2024

Dec 12, 2024

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet? - Simply Wall St

Dec 12, 2024

Dec 11, 2024

Alcon Loses Bid To Patent Improved Eye Drug At EPO - Law360

Dec 11, 2024

Dec 06, 2024

Alcon to lay off dozens of food service workers at Fort Worth campus on Christmas Eve - Yahoo! Voices

Dec 06, 2024

Dec 06, 2024

Why Alcon (ALC) is a Top Growth Stock for the Long-Term - Yahoo Finance

Dec 06, 2024

Dec 06, 2024

Alcon Inc. (ALC): A Bull Case Theory - MSN

Dec 06, 2024

Dec 03, 2024

Fuchs Endothelial Corneal Dystrophy Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | ProQR Therapeutics, Kowa Pharmac, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart

Dec 03, 2024

Dec 03, 2024

Photobiomodulation Market Overall Study Report 2024-2031 | - openPR

Dec 03, 2024

Nov 27, 2024

Dry Eye Disease Market Outlook to 2034: Insights into Epidemiology, Pipeline Developments, and Recent Regulatory Approvals by DelveInsight | Featuring Major Players Like Alcon, Allysta Pharmaceuticals - The Globe and Mail

Nov 27, 2024

Nov 26, 2024

Ocular Trauma Devices Market Is Booming Worldwide with Alcon, Zeiss, Santen - openPR

Nov 26, 2024

Nov 25, 2024

India Contact Lenses Market Forecasts and Company Analysis Report 2023-2024 & 2032 Featuring Bausch & Lomb, Alcon Laboratories, J&J, Cooper Vision, Carl Zeiss, Hoya Medical, GKB Ophthalmic and Omni - Yahoo Finance

Nov 25, 2024

Nov 25, 2024

State Rep. Alcon steps down, cites health concerns - New Mexico Political Report

Nov 25, 2024

Nov 22, 2024

Jesse Alcon Obituary (2024)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com

Nov 22, 2024

Nov 21, 2024

Alcon, '3D eye model implementation'Personal vision correction'Personal Eyes' launched in Korea - SportsChosun

Nov 21, 2024

Nov 20, 2024

What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings - MSN

Nov 20, 2024

Nov 20, 2024

Alcon cuts 2024 forecasts, as slow US hits surgical unit - MSN

Nov 20, 2024

Nov 20, 2024

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours - MSN

Nov 20, 2024

Nov 19, 2024

Impressive Earnings May Not Tell The Whole Story For Alcon (VTX:ALC) - Yahoo Finance

Nov 19, 2024

Nov 19, 2024

Lights, Camera, Lawsuit: Musk and Tesla in Hot Water Over Claimed “Blade Runner” Rip-Off - JD Supra

Nov 19, 2024

Nov 18, 2024

Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance

Nov 18, 2024

Nov 18, 2024

Most Venture Investors Want Their Startups to Go Public. Not This One. - The Wall Street Journal

Nov 18, 2024

Nov 17, 2024

Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL

Nov 17, 2024

Nov 14, 2024

Results: Alcon Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Reiterate Overweight on Alcon with $107 target post 3Q results - Investing.com

Nov 14, 2024

Nov 14, 2024

Alcon Inc. (NYSE:ALC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024

Nov 14, 2024

Alcon shares maintain Buy rating and $107 target post-results By Investing.com - Investing.com Australia

Nov 14, 2024

Nov 14, 2024

Earnings call: Alcon reports solid Q3 growth, updates full-year guidance - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Alcon: Q3, Slight Guidance Cut Is Not Something Structural - Seeking Alpha

Nov 14, 2024

Nov 13, 2024

Alcon Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

3 Focus Stocks: Alcon, Up Fintech, and Monolithic Power Systems - Baystreet.ca

Nov 13, 2024

Nov 13, 2024

ALCON : Q3 miss and an outlook downgrade should not be seen as worrisome - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Pharmaceuticals: Alcon records lower growth in the third quarter | blue News - bluewin E-Mail

Nov 13, 2024

Nov 13, 2024

Alcon Lowers Financial Outlook After US Sales Slump - Finimize

Nov 13, 2024

Nov 12, 2024

Alcon trims revenue forecast - 69News WFMZ-TV

Nov 12, 2024

Nov 12, 2024

Alcon shares maintain Buy rating and $107 target post-results - Investing.com

Nov 12, 2024

Nov 12, 2024

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation - sharewise

Nov 12, 2024

Nov 12, 2024

Alcon Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Alcon falls 6% as company trims 2024 sales outlook - MSN

Nov 12, 2024

Nov 12, 2024

Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View - MarketWatch

Nov 12, 2024

Nov 12, 2024

Alcon’s Strong Q3 2024 Results Boost Investor Confidence - TipRanks

Nov 12, 2024

Nov 11, 2024

Cell therapy startup's IPO plans thrown in limbo amid legal spat with investor Alcon - Endpoints News

Nov 11, 2024